Task: Answer the multiple-choice question.
Question: Which compound exhibits a 14.155% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: Cc1ccccc1-n1nc(C)c2cc(C(=O)N3CCN(S(=O)(=O)c4ccc(Cl)cc4)CC3)sc21
b: COc1ccc2cc3c(N)nn(C(=O)c4ccccc4Cl)c3nc2c1
c: Clc1nc(N2CCOCC2)ncc1Br
Answer: c. Clc1nc(N2CCOCC2)ncc1Br
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Clc1nc(N2CCOCC2)ncc1Br
Clc1nc(N2CCOCC2)ncc1Br
4-(5-bromo-4-chloropyrimidin-2-yl)morpholine